166 related articles for article (PubMed ID: 32206953)
1. ASO Author Reflections: Completion Axillary Dissection Can Be Avoided but Inconsistent Trial Design Complicates Choosing Between Alternative Strategies.
Castelo M; Scheer AS
Ann Surg Oncol; 2020 Aug; 27(8):2677-2678. PubMed ID: 32206953
[No Abstract] [Full Text] [Related]
2. [Optimal treatment of the axilla after positive sentinel lymph node biopsy in early invasive breast cancer. Early results of the OTOASOR trial].
Sávolt A; Musonda P; Mátrai Z; Polgár C; Rényi-Vámos F; Rubovszky G; Kovács E; Sinkovics I; Udvarhelyi N; Török K; Kásler M; Péley G
Orv Hetil; 2013 Dec; 154(49):1934-42. PubMed ID: 24292111
[TBL] [Abstract][Full Text] [Related]
3. ASO Author Reflections: Preoperative Nomogram Identifies Patients for Selective Omission of SLNB in Breast Cancer-to Promote Implementation of the Choosing Wisely Campaign Recommendations.
Tran HT; Jackson RS
Ann Surg Oncol; 2020 Aug; 27(8):2687-2688. PubMed ID: 32350715
[No Abstract] [Full Text] [Related]
4. ASO Author Reflections: Objective Outcome Measure of Upper Limb Function Following Axillary Lymph Node Dissection and Sentinel Lymph Node Biopsy.
Che Bakri NA; Kwasnicki RM; Giannas E; Tenang L; Khan N; Moenig C; Imam Z; Dhillon K; Ashrafian H; Darzi A; Leff DR
Ann Surg Oncol; 2023 Nov; 30(12):7133-7134. PubMed ID: 37482598
[No Abstract] [Full Text] [Related]
5. ASO Author Reflections: Male Breast Cancer and Axillary Lymph Node Dissection: Time to Rethink the Algorithm?
Chung SH; Cassidy MR
Ann Surg Oncol; 2023 Sep; 30(9):5619-5620. PubMed ID: 37191857
[No Abstract] [Full Text] [Related]
6. Breast cancer: can axillary lymph node dissection be avoided?
Barry M; Kell MR
Eur J Surg Oncol; 2012 Jan; 38(1):6-7. PubMed ID: 22014429
[No Abstract] [Full Text] [Related]
7. Can radiotherapy replace axillary dissection for patients with positive sentinel nodes?
Recht A
Breast Dis; 2010; 31(2):91-7. PubMed ID: 21368371
[TBL] [Abstract][Full Text] [Related]
8. ASO Author Reflection: Axillary Dissection for Negative Lymph Nodes in Inflammatory Breast Cancer-Need for Clinical Trials to Reassess Standard of Care.
Postlewait LM; Lucci A
Ann Surg Oncol; 2020 Dec; 27(Suppl 3):676-677. PubMed ID: 32737697
[No Abstract] [Full Text] [Related]
9. ASO Author Reflections: Refining Risk Assessment in Node-Positive Breast Cancer Patients Eligible for Sentinel Lymph Node Biopsy Alone.
Mamtani A; Morrow M
Ann Surg Oncol; 2020 Oct; 27(10):3593-3594. PubMed ID: 32440719
[No Abstract] [Full Text] [Related]
10. [Sentinel lymph node status and axillary lymph node dissection in the surgical treatment of breast cancer].
Cserni G
Orv Hetil; 2014 Feb; 155(6):203-15. PubMed ID: 24486844
[TBL] [Abstract][Full Text] [Related]
11. Targeted axillary dissection with preoperative tattooing of biopsied positive axillary lymph nodes in breast cancer.
Gatek J; Petru V; Kosac P; Ratajsky M; Duben J; Dudesek B; Jancik P; Zabojnikova M; Katrusak J; Opelova P; Podrazska L; Vazan P; Kudlova P; Holik P; Melichar B; Vrana D
Neoplasma; 2020 Nov; 67(6):1329-1334. PubMed ID: 32749847
[TBL] [Abstract][Full Text] [Related]
12. [Sentinel node biopsy and axillary clearence in early breast cancer--An algorithm with explanations and queries].
Cserni G
Magy Seb; 2016 Mar; 69(1):4-13. PubMed ID: 26901689
[TBL] [Abstract][Full Text] [Related]
13. Recommendation for axillary lymph node dissection in women with early breast cancer and sentinel node metastasis: A systematic review and meta-analysis of randomized controlled trials using the GRADE system.
Huang TW; Kuo KN; Chen KH; Chen C; Hou WH; Lee WH; Chao TY; Tsai JT; Su CM; Huang MT; Tam KW
Int J Surg; 2016 Oct; 34():73-80. PubMed ID: 27562691
[TBL] [Abstract][Full Text] [Related]
14. ASO Author Reflections: An Alternative to Sentinel-Node Biopsy? Preoperative Sonographic Prediction of Limited Axillary Disease in Breast Cancer Patients Meeting the Z0011 Criteria.
Radosa JC; Solomayer EF; Deeken M; Minko P; Zimmermann JSM; Kaya AC; Radosa MP; Stotz L; Huwer S; Müller C; Karsten MM; Wagenpfeil G; Radosa CG
Ann Surg Oncol; 2022 Aug; 29(8):4773-4774. PubMed ID: 35488172
[No Abstract] [Full Text] [Related]
15. [Positive sentinel node in breast cancer - when and why also opt for axillary dissection?].
Krsička P; Coufal O; Zapletal O
Rozhl Chir; 2013 Dec; 92(12):684-9. PubMed ID: 24479511
[TBL] [Abstract][Full Text] [Related]
16. ASO Author Reflections: Impact of Ipsilateral Supraclavicular Lymph Node Dissection on Breast Cancer.
Lv M; Luo S
Ann Surg Oncol; 2021 Sep; 28(9):5110-5111. PubMed ID: 33528707
[No Abstract] [Full Text] [Related]
17. Omission of axillary dissection after a positive sentinel lymph-node: Implications in the multidisciplinary treatment of operable breast cancer.
Ponzone R; Ruatta F; Gatti M; Castellano I; Geuna E; Amato G; Kubatzki F; Sgandurra P; Sapino A; Montemurro F
Cancer Treat Rev; 2016 Jul; 48():1-7. PubMed ID: 27262016
[TBL] [Abstract][Full Text] [Related]
18. Optimal Management of the Axilla: A Look at the Evidence.
Mamounas ET
Adv Surg; 2016 Sep; 50(1):29-40. PubMed ID: 27520860
[No Abstract] [Full Text] [Related]
19. [Management of the axilla in breast cancer: evidences and unresolved issues].
Fodor J; Polgár C; Péley G; Németh G
Orv Hetil; 2001 Sep; 142(36):1941-50. PubMed ID: 11680099
[TBL] [Abstract][Full Text] [Related]
20. The need for lymph node dissection in nonmetastatic breast cancer.
Pesce C; Morrow M
Annu Rev Med; 2013; 64():119-29. PubMed ID: 23020881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
